Learn more

ONCOCEUTICS INC

Overview
  • Total Patents
    87
  • GoodIP Patent Rank
    16,583
  • Filing trend
    ⇩ 7.0%
About

ONCOCEUTICS INC has a total of 87 patent applications. It decreased the IP activity by 7.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are PHARMACYCLICS LLC, SMITHKLINE BEECHAM CORK LTD and RESPROTECT GMBH.

Patent filings per year

Chart showing ONCOCEUTICS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Stogniew Martin 72
#2 Allen Joshua E 68
#3 Pottorf Richard S 46
#4 Nallaganchu Bhaskara Rao 45
#5 Olson Gary L 40
#6 Prabhu Varun Vijay 17
#7 Sun Yanjun 16
#8 Joshua E Allen 13
#9 Martin Stogniew 13
#10 Richard S Pottorf 10

Latest patents

Publication Filing date Title
US2018221375A1 Imipridones for gliomas
WO2017132661A2 G protein-coupled receptor (gpcr) modulation by imipridones
AU2016211243A1 7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-a]pyrido[3,4-e]pyrimidin-5(1h)-one, analogs and salts thereof and their use in therapy
MA41434B1 7-Benzyl-4- (4- (trifluoromethyl) benzyl) -1,2,6,7,8,9-hexahydroimidazo [1,2-a] pyrido [3,4-e] pyrimidin-5 (4h) - one, its salts and their use in therapy
CN106163524A 7 benzyl 4 (2 methyl-benzyl) 2,4,6,7,8,9 hexahydro imidazo [1,2 a] pyrido [3,4 e] pyrimidine 5 (1H) ketone, its salt and application process
US2016264574A1 7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5 (1H)-one, salts thereof and methods of using the same in combination therapy
US2014335048A1 7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, salts thereof and methods of using the same in combination therapy
WO2015073072A1 7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1h)-one
CA2905037A1 Combination therapy with 7-benzyl-10-(2-methylbenzyl)-2,6,7,8,9,10-hexahydroimidazo[1,2-a]pyrido[4,3-d]pyrimidin-5(3h)-one